| n . | % . | |
|---|---|---|
| Geographic location | ||
| Single country in Africa | 51 | 88 |
| Multiple countries in Africa | 5 | 9 |
| Multiple countries within and outside of Africa | 2 | 3 |
| Language of published article | ||
| English | 54 | 93 |
| French | 4 | 7 |
| Country of first author’s primary institutional affiliation | ||
| African country being studied | 36 | 62 |
| Other country in Africa | 2 | 3 |
| United States | 7 | 12 |
| United Kingdom | 7 | 12 |
| Other country in Europe | 3 | 5 |
| Canada | 2 | 3 |
| Japan | 1 | 2 |
| Proportion of authors with primary affiliation in Africa | ||
| All (100%) | 28 | 48 |
| A majority (50%-99%) | 10 | 17 |
| A minority (1%-49%) | 9 | 15 |
| None (zero) | 8 | 14 |
| Data not available | 3 | 5 |
| Age group of focus | ||
| Adult | 36 | 62 |
| Both adult and pediatrics | 10 | 17 |
| Pediatrics | 7 | 12 |
| Not specified | 5 | 9 |
| Clinical context | ||
| Cancer/oncology | 36 | 62 |
| Hospital | 13 | 22 |
| Palliative care or hospice | 6 | 10 |
| Community | 2 | 3 |
| Medical school | 1 | 2 |
| Study populations (not mutually exclusive; n = 103) | ||
| Patients with cancer | 25 | 24 |
| Doctors | 24 | 23 |
| Family or caregivers | 16 | 15 |
| Nurses | 16 | 15 |
| Other | 15 | 15 |
| Patients with serious illness | 7 | 7 |
| Study type per MMAT designations | ||
| Quantitative descriptive | 31 | 53 |
| Qualitative only | 22 | 38 |
| Non-randomized experimental | 3 | 5 |
| Mixed methods | 2 | 3 |
| Data collection methods (not mutually exclusive; n = 75) | ||
| Survey using novel or adapted instrument | 32 | 42 |
| Qualitative interviews | 20 | 26 |
| Survey using established instrument | 7 | 9 |
| Qualitative focus groups | 6 | 8 |
| Ethnographic observation | 5 | 7 |
| Medical record review | 4 | 5 |
| Survey instrument validation | 1 | 1 |
| Key document review | 1 | 1 |
| n . | % . | |
|---|---|---|
| Geographic location | ||
| Single country in Africa | 51 | 88 |
| Multiple countries in Africa | 5 | 9 |
| Multiple countries within and outside of Africa | 2 | 3 |
| Language of published article | ||
| English | 54 | 93 |
| French | 4 | 7 |
| Country of first author’s primary institutional affiliation | ||
| African country being studied | 36 | 62 |
| Other country in Africa | 2 | 3 |
| United States | 7 | 12 |
| United Kingdom | 7 | 12 |
| Other country in Europe | 3 | 5 |
| Canada | 2 | 3 |
| Japan | 1 | 2 |
| Proportion of authors with primary affiliation in Africa | ||
| All (100%) | 28 | 48 |
| A majority (50%-99%) | 10 | 17 |
| A minority (1%-49%) | 9 | 15 |
| None (zero) | 8 | 14 |
| Data not available | 3 | 5 |
| Age group of focus | ||
| Adult | 36 | 62 |
| Both adult and pediatrics | 10 | 17 |
| Pediatrics | 7 | 12 |
| Not specified | 5 | 9 |
| Clinical context | ||
| Cancer/oncology | 36 | 62 |
| Hospital | 13 | 22 |
| Palliative care or hospice | 6 | 10 |
| Community | 2 | 3 |
| Medical school | 1 | 2 |
| Study populations (not mutually exclusive; n = 103) | ||
| Patients with cancer | 25 | 24 |
| Doctors | 24 | 23 |
| Family or caregivers | 16 | 15 |
| Nurses | 16 | 15 |
| Other | 15 | 15 |
| Patients with serious illness | 7 | 7 |
| Study type per MMAT designations | ||
| Quantitative descriptive | 31 | 53 |
| Qualitative only | 22 | 38 |
| Non-randomized experimental | 3 | 5 |
| Mixed methods | 2 | 3 |
| Data collection methods (not mutually exclusive; n = 75) | ||
| Survey using novel or adapted instrument | 32 | 42 |
| Qualitative interviews | 20 | 26 |
| Survey using established instrument | 7 | 9 |
| Qualitative focus groups | 6 | 8 |
| Ethnographic observation | 5 | 7 |
| Medical record review | 4 | 5 |
| Survey instrument validation | 1 | 1 |
| Key document review | 1 | 1 |
| n . | % . | |
|---|---|---|
| Geographic location | ||
| Single country in Africa | 51 | 88 |
| Multiple countries in Africa | 5 | 9 |
| Multiple countries within and outside of Africa | 2 | 3 |
| Language of published article | ||
| English | 54 | 93 |
| French | 4 | 7 |
| Country of first author’s primary institutional affiliation | ||
| African country being studied | 36 | 62 |
| Other country in Africa | 2 | 3 |
| United States | 7 | 12 |
| United Kingdom | 7 | 12 |
| Other country in Europe | 3 | 5 |
| Canada | 2 | 3 |
| Japan | 1 | 2 |
| Proportion of authors with primary affiliation in Africa | ||
| All (100%) | 28 | 48 |
| A majority (50%-99%) | 10 | 17 |
| A minority (1%-49%) | 9 | 15 |
| None (zero) | 8 | 14 |
| Data not available | 3 | 5 |
| Age group of focus | ||
| Adult | 36 | 62 |
| Both adult and pediatrics | 10 | 17 |
| Pediatrics | 7 | 12 |
| Not specified | 5 | 9 |
| Clinical context | ||
| Cancer/oncology | 36 | 62 |
| Hospital | 13 | 22 |
| Palliative care or hospice | 6 | 10 |
| Community | 2 | 3 |
| Medical school | 1 | 2 |
| Study populations (not mutually exclusive; n = 103) | ||
| Patients with cancer | 25 | 24 |
| Doctors | 24 | 23 |
| Family or caregivers | 16 | 15 |
| Nurses | 16 | 15 |
| Other | 15 | 15 |
| Patients with serious illness | 7 | 7 |
| Study type per MMAT designations | ||
| Quantitative descriptive | 31 | 53 |
| Qualitative only | 22 | 38 |
| Non-randomized experimental | 3 | 5 |
| Mixed methods | 2 | 3 |
| Data collection methods (not mutually exclusive; n = 75) | ||
| Survey using novel or adapted instrument | 32 | 42 |
| Qualitative interviews | 20 | 26 |
| Survey using established instrument | 7 | 9 |
| Qualitative focus groups | 6 | 8 |
| Ethnographic observation | 5 | 7 |
| Medical record review | 4 | 5 |
| Survey instrument validation | 1 | 1 |
| Key document review | 1 | 1 |
| n . | % . | |
|---|---|---|
| Geographic location | ||
| Single country in Africa | 51 | 88 |
| Multiple countries in Africa | 5 | 9 |
| Multiple countries within and outside of Africa | 2 | 3 |
| Language of published article | ||
| English | 54 | 93 |
| French | 4 | 7 |
| Country of first author’s primary institutional affiliation | ||
| African country being studied | 36 | 62 |
| Other country in Africa | 2 | 3 |
| United States | 7 | 12 |
| United Kingdom | 7 | 12 |
| Other country in Europe | 3 | 5 |
| Canada | 2 | 3 |
| Japan | 1 | 2 |
| Proportion of authors with primary affiliation in Africa | ||
| All (100%) | 28 | 48 |
| A majority (50%-99%) | 10 | 17 |
| A minority (1%-49%) | 9 | 15 |
| None (zero) | 8 | 14 |
| Data not available | 3 | 5 |
| Age group of focus | ||
| Adult | 36 | 62 |
| Both adult and pediatrics | 10 | 17 |
| Pediatrics | 7 | 12 |
| Not specified | 5 | 9 |
| Clinical context | ||
| Cancer/oncology | 36 | 62 |
| Hospital | 13 | 22 |
| Palliative care or hospice | 6 | 10 |
| Community | 2 | 3 |
| Medical school | 1 | 2 |
| Study populations (not mutually exclusive; n = 103) | ||
| Patients with cancer | 25 | 24 |
| Doctors | 24 | 23 |
| Family or caregivers | 16 | 15 |
| Nurses | 16 | 15 |
| Other | 15 | 15 |
| Patients with serious illness | 7 | 7 |
| Study type per MMAT designations | ||
| Quantitative descriptive | 31 | 53 |
| Qualitative only | 22 | 38 |
| Non-randomized experimental | 3 | 5 |
| Mixed methods | 2 | 3 |
| Data collection methods (not mutually exclusive; n = 75) | ||
| Survey using novel or adapted instrument | 32 | 42 |
| Qualitative interviews | 20 | 26 |
| Survey using established instrument | 7 | 9 |
| Qualitative focus groups | 6 | 8 |
| Ethnographic observation | 5 | 7 |
| Medical record review | 4 | 5 |
| Survey instrument validation | 1 | 1 |
| Key document review | 1 | 1 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
